DuPont (DD) CEO exercises 9,011 options and sells 9,011 shares in Nov 2025

Rhea-AI Filing Summary

DuPont de Nemours, Inc. reported an insider transaction by its CEO and director on 11/28/2025. The reporting person exercised 9,011 stock options with an exercise price of $28 per share, acquiring the same number of DuPont common shares. On the same date, the insider sold 9,011 shares of common stock in an open-market transaction coded as a sale.

The sale had a weighted average price of $39.4619, with trades ranging from $39.46 to $39.48. Following these transactions, the insider directly beneficially owned 288,325.6878 shares of DuPont common stock. The stock options involved were non-qualified options granted on 02/03/2019 with an expiration date of 02/02/2026, vesting in three substantially equal annual installments.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Koch Lori

(Last) (First) (Middle)

CHESTNUT RUN PLAZA 730

974 CENTRE ROAD

(Street)

WILMINGTON DE 19805

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DuPont de Nemours, Inc. [ DD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

3. Date of Earliest Transaction (Month/Day/Year)
11/28/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/28/2025		M		9,011	A	$28	297,336.6878	D
Common Stock	11/28/2025		S		9,011	D	$39.46(1)	288,325.6878	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy NQOs)	$28	11/28/2025		M		9,011		02/03/2019(2)	02/02/2026	Common Stock	9,011	$0	0	D

Explanation of Responses:

1. Weighted average sales price of $39.4619. Trades ranged from $39.46 to $39.48. Upon request, the reporting person will provide to the Commission, the issuer and any stockholder full information regarding the number of shares that were sold at each separate price.

2. Options become exercisable in three substantially equal installments beginning on the first anniversary of the grant; option shares may be used to satisfy withholding taxes.

Remarks:

	Paige Fleming By Power of Attorney	12/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DuPont (DD) report for its CEO on November 28, 2025?

DuPont reported that its CEO and director exercised 9,011 stock options at an exercise price of $28 per share and sold 9,011 shares of common stock on 11/28/2025.

How many DuPont (DD) shares does the reporting person own after the November 28, 2025 transaction?

After the reported transactions on 11/28/2025, the reporting person directly beneficially owned 288,325.6878 shares of DuPont common stock.

What was the sale price range for the DuPont (DD) shares sold on November 28, 2025?

The weighted average sales price was $39.4619 per share, with individual trades ranging from $39.46 to $39.48 on 11/28/2025.

What type of derivative security did the DuPont (DD) insider exercise?

The insider exercised stock options (Right to Buy NQOs) covering 9,011 shares of DuPont common stock at an exercise price of $28 per share.

When were the DuPont (DD) stock options granted and when do they expire?

The stock options were granted on 02/03/2019 and have an expiration date of 02/02/2026. They become exercisable in three substantially equal installments beginning on the first anniversary of the grant.

What vesting terms apply to the DuPont (DD) stock options reported in this Form 4?

The options become exercisable in three substantially equal installments, beginning on the first anniversary of the 02/03/2019 grant date, and option shares may be used to satisfy withholding taxes.